BLLN Stock Analysis: Buy, Sell, or Hold?
$82.51
1.30 (1.60%)
▲
5d:
-5.78%
30d:
-3.03%
90d:
+0%
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 25, 2026
Get Alerted When BLLN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BLLN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: BLLN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$18.50
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$11.49
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLLN is currently trading at $82.51, which is considered oversold relative to its 30-day fair value range of $83.77 to $93.43. The stock's valuation (Forward PE: 217.1) is in line with its historical norms (224.5). Remarkably, the market is currently pricing in an annual earnings decline of 1.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BLLN is in a downtrend. Immediate support is located at $80.00, while resistance sits at $95.35.
Market Sentiment: BLLN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $135.29 (+64.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BLLN is in a downtrend. Immediate support is located at $80.00, while resistance sits at $95.35.
Market Sentiment: BLLN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $135.29 (+64.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$83.77 -
$93.43
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 64.0% below Wall St target ($135.29)
- CAUTION: 5-day price weakness (-5.8%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$83.77 -
$93.43
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$80.00
Resistance Level
$95.35
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
217.13
Wall Street Target
$135.29
(+64.0%)
Revenue Growth (YoY)
117.4%
Profit Margin
-4.4%
Valuation Discount vs History
-1.1% cheaper
PE vs Historical
217.1 vs 224.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.1%
(market-implied from PE analysis)
1-Year Target
$81.60
(-1%)
2-Year Target
$80.70
(-2%)
3-Year Target
$79.82
(-3%)
3-Yr Target (if PE normalizes)
(PE: 217→225)
$82.53
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 217.1, Growth: 28.8%)
$176.36
(+114%)
Base:
(SPY PE: 22.3, Growth: 28.8%)
$18.11
(-78%)
Bear:
(PE: 19.0, Growth: 28.8%)
$15.40
(-81%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 217.1 to 224.5
Stabilization Target:
$85.31
(+3.4%)
PE Expansion Potential:
+3.4%
Last updated: February 02, 2026 6:23 AM ET
Data refreshes hourly during market hours. Next update: 7:23 AM
Data refreshes hourly during market hours. Next update: 7:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLLN showing a specific setup today?
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$666 | 47 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$125 | 62 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 47 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 58 HOLD |